Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazim Abbas

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Medical Case Reports|September 21, 2021
Sorafenib-related generalized eruptive keratoacanthomas (Grzybowski syndrome): a case reportM Nazim Abbas, Wei Son Tan, Ganessan Kichenadasse
Discover Nano|May 10, 2026
Matrix-free, color-tunable carbon quantum dots with solid-state emission for white LEDsNiqash Zaman, Nazim Abbas, Aumber Abbas, et al.
Cancer Reports (Hoboken, N.J.)|July 1, 2021
Real-world experience of nivolumab in the treatment of poor performance status patients with advanced non-small cell lung cancerM Nazim Abbas, Myron Klevansky, Bogda Koczwara, et al.
Clinical & Translational Immunology|January 17, 2017
GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells <i>in vitro</i>Tessa Gargett, Susan N Christo, Timothy R Hercus, et al.
BMJ Open|May 8, 2019
Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocolSina Vatandoust, Tim Bright, Amitesh Chandra Roy, et al.
ANZ Journal of Surgery|October 7, 2021
Patterns of care and outcomes for gastric and gastro-oesophageal junction cancer in an Australian populationM Nazim Abbas, Tim Bright, Timothy Price, et al.
Cancer Reports (Hoboken, N.J.)|March 4, 2021
Predicting chemotherapy-induced menopause using baseline and post-chemotherapy anti-Müllerian hormone levels: Results of a pilot studyHilary Laura Martin, Shahid Ullah, Nazim Abbas, et al.
Asia-Pacific Journal of Clinical Oncology|November 23, 2021
Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study)Sina Vatandoust, Tim Bright, Amitesh Chandra Roy, et al.
Cancer Immunology, Immunotherapy : CII|July 18, 2018
Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanomaTessa Gargett, M Nazim Abbas, Paul Rolan, et al.
Journal of Thoracic Disease|November 19, 2019
Survival and late toxicities following concurrent chemo-radiotherapy for locally advanced stage III non-small cell lung cancer: findings of a 10-year Australian single centre experience with long term clinical follow upM Nazim Abbas, Adeola Ayoola, Sunita Padman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Medical Case Reports|September 21, 2021
Sorafenib-related generalized eruptive keratoacanthomas (Grzybowski syndrome): a case reportM Nazim Abbas, Wei Son Tan, Ganessan Kichenadasse
Discover Nano|May 10, 2026
Matrix-free, color-tunable carbon quantum dots with solid-state emission for white LEDsNiqash Zaman, Nazim Abbas, Aumber Abbas, et al.
Cancer Reports (Hoboken, N.J.)|July 1, 2021
Real-world experience of nivolumab in the treatment of poor performance status patients with advanced non-small cell lung cancerM Nazim Abbas, Myron Klevansky, Bogda Koczwara, et al.
Clinical & Translational Immunology|January 17, 2017
GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells <i>in vitro</i>Tessa Gargett, Susan N Christo, Timothy R Hercus, et al.
BMJ Open|May 8, 2019
Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocolSina Vatandoust, Tim Bright, Amitesh Chandra Roy, et al.
ANZ Journal of Surgery|October 7, 2021
Patterns of care and outcomes for gastric and gastro-oesophageal junction cancer in an Australian populationM Nazim Abbas, Tim Bright, Timothy Price, et al.
Cancer Reports (Hoboken, N.J.)|March 4, 2021
Predicting chemotherapy-induced menopause using baseline and post-chemotherapy anti-Müllerian hormone levels: Results of a pilot studyHilary Laura Martin, Shahid Ullah, Nazim Abbas, et al.
Asia-Pacific Journal of Clinical Oncology|November 23, 2021
Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study)Sina Vatandoust, Tim Bright, Amitesh Chandra Roy, et al.
Cancer Immunology, Immunotherapy : CII|July 18, 2018
Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanomaTessa Gargett, M Nazim Abbas, Paul Rolan, et al.
Journal of Thoracic Disease|November 19, 2019
Survival and late toxicities following concurrent chemo-radiotherapy for locally advanced stage III non-small cell lung cancer: findings of a 10-year Australian single centre experience with long term clinical follow upM Nazim Abbas, Adeola Ayoola, Sunita Padman, et al.
Pageof 2